In short
Medtronic plc (MDT) has revenue up 8.4% to $36.4B and net income up 3.0% to $4.8B year on year. Its net margin is 13.2%, and it trades at 21.6× trailing earnings. Fisclear found no medium- or high-severity risk flags in this filing. How we calculate this
Compare: JNJ vs MDT · ABT vs MDT · BAX vs MDT · BDX vs MDT
Valuation
HealthcareLive · Yahoo FinancePrice
$99.94
$127.8B
14.2x
2.88%
52-Week Range
Decision Context
Scores are balanced across the six engines. No single dimension dominates — this is consistent with a stable, mid-tier quality business.
Based on filing period ending Jul 2026
FisclearScore is a quantitative model using public financial data and sector median benchmarks (refreshed monthly). Not financial advice. Always conduct independent due diligence.
Macro Context
Fed Funds Rate
3.75%
Accommodative
10-Year Treasury
4.99%
2026-09-01
Unemployment
4.2%
Near full employment
CPI Index
334.1
2026-08-01
M2 Money Supply
$23.3T
2026-08-01
The Federal Funds rate stands at 3.75% — a moderately elevated rate environment that raises borrowing costs across the economy; 10-year Treasury yields are at 4.99%, setting the benchmark for long-term corporate borrowing; Unemployment stands at 4.2%; Industrial production index is at 103.1; M2 money supply is $23.3T; CPI index stands at 334.1.
SWOT Analysis — MDT
Inflationary BoomStrengths
Revenue: $36.4B (+8.4% YoY) — Revenue grew 8% — the company sold more goods or services than the prior year.
Weaknesses
No material weaknesses flagged.
Opportunities
Operating Cash Flow: $7.3B (+4.1% YoY) — Operating cash flow grew 4% — the business generated more cash from day-to-day operations.
EPS (Diluted): $3.73 (+3.3% YoY) — Earnings per share rose 3% — each share earned more.
Net Income: $4.8B (+3.0% YoY) — Profit grew 3% — the company kept more of each dollar earned.
Total Assets: $93.0B (+1.5% YoY) — Total assets grew 1% — the company's resource base expanded.
Threats
No significant threats flagged.
Quarter-over-Quarter Comparison
2026-04-24 → 2026-07-31| Metric | 2026-04-24 | 2026-07-31 | Change |
|---|---|---|---|
| Revenue | $36.4B | $36.4B | –0.0% |
| Gross Profit | $3.7B | 0.00 | ▼100.0% |
| Operating Income | $6.5B | $6.5B | –0.0% |
| Net Income | $4.8B | $4.8B | –0.0% |
| EPS (diluted) | $3.73 | $3.73 | –0.0% |
| Operating CF | $7.3B | $7.3B | –0.0% |
Risk factor changes vs prior filing
Gross margin narrowed by 5.6pp — worth monitoring for further cost pressure.
Year-over-Year Changes
Revenue
$36.4B
was $33.5B
Revenue grew 8% — the company sold more goods or services than the prior year.
Operating Cash Flow
$7.3B
was $7.0B
Operating cash flow grew 4% — the business generated more cash from day-to-day operations.
EPS (Diluted)
$3.73
was $3.61
Earnings per share rose 3% — each share earned more.
Net Income
$4.8B
was $4.7B
Profit grew 3% — the company kept more of each dollar earned.
Total Assets
$93.0B
was $91.7B
Total assets grew 1% — the company's resource base expanded.
Technical Signals
Daily closes · 1-year dataMedtronic plc: common questions
Is Medtronic plc profitable?
Yes. Medtronic plc made a net profit of $4.8B in its latest fiscal year (fiscal 2026), a net margin of 13.2%.
Is Medtronic plc's revenue growing?
Yes. Revenue grew 8.4% year on year, to $36.4B.
What is Medtronic plc's P/E ratio?
Medtronic plc trades at 24.6× its trailing twelve-month earnings. In other words, the share price is about 25 times the profit per share the company earned over the past year.
Does Medtronic plc pay a dividend?
Yes. Medtronic plc's forward dividend yield is 2.88%, the expected annual dividend as a share of the current share price.
Answers are generated from the figures in this report (updated 9 Oct 2026). Information, not investment advice.
Latest News
via FinnhubFiling History — MDT
Get the weekly digest
5 company reports + macro context every week, free. No spam.
- Unlimited goal simulations
- 5 free company report summaries per day
- Weekly financial insights newsletter
External Links
Trade MDT
Links open broker research pages. Not an endorsement or recommendation.
Research Medtronic plc
Data sourced from SEC EDGAR, FRED (Federal Reserve Economic Data), and Yahoo Finance. For informational purposes only. Not financial advice.